# Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

> **NCT00898690** · — · UNKNOWN · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 120 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **GENETIC:** cytogenetic analysis
- **GENETIC:** gene expression analysis
- **GENETIC:** microarray analysis
- **GENETIC:** mutation analysis
- **GENETIC:** reverse transcriptase-polymerase chain reaction
- **OTHER:** immunohistochemistry staining method

## Key facts

- **NCT ID:** NCT00898690
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2013-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898690, "Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00898690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*